期刊文献+

希罗达联合放射治疗对早期食道癌患者疗效观察 被引量:1

Xeloda in combination with radiotherapy in patients with early esophageal cancer
下载PDF
导出
摘要 目的:探讨对早期食道癌患者应用希罗达对放射治疗的增敏作用。方法:对131例早期食管癌患者进行希罗达联合放射治疗,并与同期单存放疗患者比较。结果:联合组对患者完全缓解率有影响,能提高患者完全缓解率,联合组总有效率高于单纯放疗组声音嘶哑因为例数太小无法进行比较,患者吞咽困难改善率,联合组优于单纯放疗组,对胸痛影响无差异,且两组治疗患者均未见Ⅲ级以上明显不良反应。结论:联合治疗效果优于单纯放射治疗,希罗达对放射治疗有增敏作用。 Objective To explore the application of Xeloda in patients with early esophageal cancer on the sensitizing effect of radiation therapy.Methods The hospital in January 2007 to December 2009 Radiotherapy of early esophageal cancer were treated 131 patients in Hilo over the same period in combination with radiotherapy and radiotherapy in patients with a single deposit comparison.Results The CR rate in combination group of patients affected,can improve the CR rate in patients,the joint group was more efficient than radiotherapy alone group had a hoarse voice because of the number of cases is too small to compare patients dysphagia improvement rate,the joint group was better than radiotherapy alone group,no difference in the impact of chest pain,and patients treated groups were no apparent toxic effects of grade Ⅲ and above.Conclusion The combination therapy was superior to radiotherapy alone,Xeloda on the radiation sensitizing effect of treatment.
作者 吴庭安
出处 《吉林医学》 CAS 2010年第15期2172-2173,共2页 Jilin Medical Journal
关键词 希罗达 放射治疗 早期食道癌 增敏 Capecitabine Radiation therapy Early esophageal cancer Sensitizer
  • 相关文献

参考文献6

二级参考文献19

  • 1冯斌,刘继红,郭其森,宋丽华,张燕,张保轩,孙亚红,湛玉静.卡培他滨联合顺铂治疗复治的晚期食管癌胃癌[J].中国癌症杂志,2005,15(1):96-96. 被引量:1
  • 2徐克友,邹宏志,赵北永,郭庆伟,曹晓东.希罗达治疗晚期癌症临床观察[J].中国肿瘤临床与康复,2005,12(1):66-67. 被引量:4
  • 3VokesEE GolombHM 张小乐主译.肿瘤治疗学[M].北京:人民卫生出版社,2001.661-664.
  • 4Chua DT, Sham JS, Kwong DL, et al. Treatment outcome after radiotherapy alone for patients with Stage Ⅰ-Ⅱ nasopharyngeal carcinoma. Cancer, 2003,98:74-80.
  • 5Cheng SH, Tsai SY, Yen KL, et al. Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma. J Clin Oncol, 2000,18:2040-2045.
  • 6Smalley SR, Kimler BF, Evans RG. 5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int J Radiat Oncol Biol Phys, 1991,20:207-211.
  • 7O′Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med, 1994,331:502-507.
  • 8Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys, 2000,47:13-47.
  • 9Blum JL, Jones SE, Buzdar AU, et al. Multicenter phase Ⅱ study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol,1999,17:485-493.
  • 10Sawada N, Ishikawa T, Sekiguchi F, et al. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res, 1999,5:2948-2953.

共引文献32

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部